Product Browser

Last updated: 2017/11/19

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

CytoQuest™ Neuroblastoma CSV CSV CD45 Antibody Kit

  • Catalog # : KA4911
  • Visit Frequency :
  • Countries :
  • Specification
  • Product Description:
  • CytoQuest™ Neuroblastoma CSV CSV CD45 Antibody Kit contains antibodies and reagents for immobilization and immunostaining of neuroblastoma circulating tumor cells (CTCs) in peripheral blood and disseminated tumor cells (DTCs) in bone marrow.
  • Supplied Product:
  • Kit content:
    1. Anti-CSV capturing antibody (Biotin):
    Biotin conjugated Anti-CSV antibody for circulating sarcoma cell capturing.

    2. Anti-CSV detecting antibody (FITC):
    FITC conjugated Anti-CSV antibody for circulating sarcoma cell detection.

    3. Anti-CD45 detecting antibody (PE):
    PE conjugated Anti-CD45 antibody for circulating sarcoma cell detection.

    4. 50X Antibody Dilution Buffer (50X ADB).

    *Reagents are sufficient for 20 assays using recommended protocol.
  • Storage Instruction:
  • Store Anti-CSV capturing antibody (Biotin), Anti-CSV detecting antibody (FITC) and Anti-CD45 detecting antibody (PE) at 4°C.

    Store 50X Antibody Dilution Buffer (50X ADB) at -20°C.

    Aliquot to avoid repeated freezing and thawing.
  • Regulatory Status:
  • For research use only (RUO)
  • Applications
  • Immunofluorescence (Circulating Tumor Cell)
  • Immunofluorescence (Circulating Tumor Cell)
  • Representative images of CTC (upper image, white arrow) and DTCs (lower image, white arrow) on two separate CytoChipNano CR from neuroblastoma patient. CTCs and DTCs were detected by using immunofluorescence staining for CSV (FITC, green), CD45 (PE, orange) and Nucleus (Hoechst, blue).
  • Application Image
  • Immunofluorescence (Circulating Tumor Cell)
  • Immunofluorescence (Circulating Tumor Cell)
  • enlarge
  • RSS
  • YouTube
  • Linkedin
  • Facebook